Cough Syrup: An Extensive Review on Types, Drug Profile, Mechanism of Action, Side Effects and Precautions

Abstract

Cough syrups are liquid formulations intention to treat various cough types and exploiting active ingredients which carries Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate for the symptomatic treatment of dry cough and common cold. Chlorpheniramine is an antihistamine that relieves allergic indications such as sneezing and runny nose. Dextromethorphan acts as a centrally acting antitussive that suppresses the cough reflex. Phenylephrine is a nasal decongestant that impairs nasal congestion by vasoconstriction. The admixture therapy provides effective relief from dry cough, nasal blockage, and allergy- associated symptoms in upper respiratory tract infections. The formulation is predominantly administered orally in syrup form, ensuring rapid absorption and advanced patient compliance, notably in pediatric and geriatric populations. Consequently, this multidrug cough syrup offers a comprehensive and synergistic approach for the management of cough and common cold symptoms

Keywords

Introduction

The intentional or reflexive action that clears the throat and breathing route of foreign particles, bacteria, irritants, fluids, and mucus is simply cough. "Tussis" is the precursor of "cough."  Liquid medicinal formulations designed to alleviate cough symptoms are called cough syrups. 

It contains active chemicals that inhibit or loosen coughing and comes in a variety of forms.

Effective symptom control requires an understanding of its utilization. 

Depending on the kind of cough you have, they often fall into one of two categories:  

 suppressants (for "dry" hacking coughs) and expectorants (for "wet" productive coughs).  Expectorants are used to treat wet cough or coughing up mucus. They facilitate the mucus's easier removal from the body by loosening it. It facilitates more productive coughing and opens the airways. 

Another name for suppressants is "antitussive." By working on the cough center in the brain's medulla, it suppresses both the cough impulse and the cough reflex.

DRUG PROFILE ^[3-10]:

Dextromethorphan Hydrobromide:

History:

Due to its effectiveness and reduced risk for abuse at therapeutic dosages, dextromethorphan hydrobromide, a non-opioid antitussive that was developed in 1949 and approved by the FDA in 1958, has supplanted codeine in many cough medications. It suppresses coughs by acting on the medulla and is frequently used as an over-the-counter treatment. At large dosages, it may also have dissociative effects.

Structure:

 

 

Mechanism of Action:

In addition to having moderate serotonin reuptake inhibitory effects, dextromethorphan HBr suppresses cough via acting centrally on the cough center in the medulla, mostly through NMDA receptor antagonism and sigma-1 receptor agonism.

Phenylephrine Hydrochloride:

History:

Explicated in 1933, phenylephrine hydrochloride began to be used in medicine in 1938 as a synthetic, non-addictive vasoconstrictor to lower blood pressure. It changed previous stimulants like ephedrine and was utilized as a nasal decongestant in several over-the-counter (OTC) cold medications. But in 2023–2024, the FDA concluded that oral tablets are essentially ineffectual after decades of research. 

Structure:

 

 

Mechanism of Action:

Vasoconstriction and pupil dilatation (mydriasis) are brought on by phenylephrine's direct activation of alpha-1 adrenergic receptors. By narrowing the majority of arterial beds, including the renal and hepatic arteries, it increases blood pressure and peripheral vascular resistance. Bradycardia may result from the vagal reflex being triggered by this vasoconstriction.

Chlorpheniramine Maleate:

History:

Introduced in the early 1950s following its 1948 patent, chlorpheniramine maleate is a traditional "first-generation" antihistamine that works by inhibiting histamine to treat cold symptoms, hay fever, and allergies. It reduces sneezing, runny nose, and itching fast (within 30 to 60 minutes), however it frequently causes drowsiness.

 

Structure:

 

 

Mechanism of Action:

Chlorpheniramine maleate blocks histamine's effects at the body's H1 receptors, making it a powerful antihistamine. By attaching itself to these receptors, it prevents histamine from causing allergic reactions, including runny nose, itchy eyes, and sneezing.

SIDE EFFECTS ^[11]:

• Drowsiness
• Dizziness
• Dry mouth/nose/throat
• Nervousness
• Restlessness

 PRECAUTIONS ^[11]:

The drug is used to treat colds and coughs, and it should be taken with sufficient caution to prevent any negative effects. The syrup effectively relieves pain when used as prescribed.

• If you have diabetes, heart disease, high blood pressure, thyroid problems, glaucoma, urinary problems, or an enlarged prostate, see a doctor first.
• Do not take monoamine oxidase inhibitors during the last 14 days.
• To avoid taking too much of this medication, avoid using it with other antihistamines, mental health drugs, or cold remedies.
• If symptoms last longer than seven days and are accompanied by a high fever, rash, or headache, see your physician.
• Women who are nursing or pregnant should not use the syrup.
• It is not appropriate for people with asthma or chronic coughs brought on by smoking.

 CONCLUSION

An efficient, quick-acting medication for the short-term alleviation of dry cough, nasal congestion, and allergy symptoms is the combination of dextromethorphan HBr (cough suppressant), phenylephrine Hcl (decongestant), and chlorpheniramine maleate (antihistamine).

• Dextromethorphan Hydrobromide suppresses dry cough by acting as an antitussive.
• Chlorpheniramine Maleate is an antihistamine that lessens runny nose and sneezing, two signs of allergies.
• A nasal decongestant that reduces nasal congestion is phenylephrine HCL.
• By combining a cough suppressant, a nasal decongestant, and an antihistamine, it provides a multi-symptom alleviation strategy for the common cold, flu, and allergic respiratory disorders, making it a practical and all-encompassing treatment for coldrelated discomforts.

REFERENCES

1. Nancy choi MD, Tim Newman, "All about Coughs and their causes", 2017.
2. Introduction-to-Cough-Syrup. .... medicine

https://share.google/1Q8F6wmYRWBo9RkQx

3. McClure EW, Daniels RN, “Classics in Chemical Neuroscience: Dextromethorphan (DXM).” ACS Chem Neurosci; June 2023;14(12):22562270.
4. “Dextromethorphan Hydrobromide”, September 2025

https://share.google/sRJpEXFSWXiRaAjnM

5.  Fischer J, Ganellin CR (2006), “Analogue-based Drug Discovery.” John Wiley & Sons, p. 541, ISBN 9783527607495.
6. Hatton RC, Hendeles L (March 2022), “Why Is Oral Phenylephrine on the Market

After Compelling Evidence of Its Ineffectiveness as a Decongestant?”. Ann Pharmacother; 56 (11): 1275–1278.

7. “Phenylephrine Hydrochloride”, September 2025 https://share.google/Bqoqc24uzAaS0LKj7
8. “Over-the-Counter Medicines for Allergies”. Health Link BC. Archived from the original on 15 July 2019, Retrieved 15 July 2019.
9. “Chlorpheniramine”, Drugs.com. American Society of Health-System Pharmacists, 26 July 2023. Archived from the original on 20 August 2023, Retrieved 20 August 2023.
10. “Chlorpheniramine”, April 1975

https://share.google/XipoDSjDvObvVqXEC

11. “Dextromethorphan Hydrobromide 10mg, Chlorpheniramine Maleate 2mg & Phenylephrine Hydrochloride 5mg Syrup”, 2020 https://www.medxonehealthcare.com/CURICT- DC#:~:text=Dextromethorphan%20Hydrobromide%2C%20Chlorpheniramine%20Maleate%2

0and,from%20sneezing%20and%20runny%20nose